Suppression of the Transformed Phenotype and Induction of Differentiation-Like Characteristics in Cultured Ovarian Tumor Cells by Chronic Treatment with Progesterone

Martina Blumenthal, Adel Kardosh, Louis Dubeau, Zea Borok, Axel H. Schönthal

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Epidemiological evidence suggests that elevated levels of the pregnancy hormone progesterone might play a role in the reduced risk of women to develop ovarian cancer. In vitro studies have supported this hypothesis by demonstrating negative effects of this hormone on the growth and proliferation of cultured ovarian carcinoma cells. However, little is known about the underlying molecular processes and how progesterone might decrease the risk for ovarian tumors. Therefore, we investigated the effects of chronic hormone treatment on the cell-cycle and transformed phenotype of ovarian carcinoma cell lines in vitro. We found that long-term treatment of these cells with progesterone caused a concomitant reduction of cyclin-dependent kinase (CDK) activity. In parallel, these cells lost their transformed phenotype as indicated by the acquisition of contact inhibition and the loss of anchorage-independence, as well as the reduced expression of tumor markers such as heat shock protein (HSP) 72 and carcinoma antigen (CA) 125. In addition, progesterone-treated cells exhibited characteristics that resembled a more differentiated phenotype. Taken together, our data indicated that progesterone was able to suppress the transformed phenotype of ovarian tumor cells. This observation could serve to explain progesterone's alleged protective effect in ovarian carcinogenesis.

Original languageEnglish (US)
Pages (from-to)160-169
Number of pages10
JournalMolecular Carcinogenesis
Volume38
Issue number4
DOIs
StatePublished - Dec 1 2003
Externally publishedYes

Fingerprint

Cultured Tumor Cells
Progesterone
Phenotype
Carcinoma
Therapeutics
HSP72 Heat-Shock Proteins
Hormones
Contact Inhibition
Cyclin-Dependent Kinases
Tumor Biomarkers
Ovarian Neoplasms
Growth Hormone
Neoplasms
Cell Cycle
Carcinogenesis
Antigens
Cell Line
Pregnancy

Keywords

  • Cell-cycle
  • Differentiation
  • Ovarian carcinoma
  • Progesterone

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Suppression of the Transformed Phenotype and Induction of Differentiation-Like Characteristics in Cultured Ovarian Tumor Cells by Chronic Treatment with Progesterone. / Blumenthal, Martina; Kardosh, Adel; Dubeau, Louis; Borok, Zea; Schönthal, Axel H.

In: Molecular Carcinogenesis, Vol. 38, No. 4, 01.12.2003, p. 160-169.

Research output: Contribution to journalArticle

@article{dcfb0a2b8161407a944f00dffe99af74,
title = "Suppression of the Transformed Phenotype and Induction of Differentiation-Like Characteristics in Cultured Ovarian Tumor Cells by Chronic Treatment with Progesterone",
abstract = "Epidemiological evidence suggests that elevated levels of the pregnancy hormone progesterone might play a role in the reduced risk of women to develop ovarian cancer. In vitro studies have supported this hypothesis by demonstrating negative effects of this hormone on the growth and proliferation of cultured ovarian carcinoma cells. However, little is known about the underlying molecular processes and how progesterone might decrease the risk for ovarian tumors. Therefore, we investigated the effects of chronic hormone treatment on the cell-cycle and transformed phenotype of ovarian carcinoma cell lines in vitro. We found that long-term treatment of these cells with progesterone caused a concomitant reduction of cyclin-dependent kinase (CDK) activity. In parallel, these cells lost their transformed phenotype as indicated by the acquisition of contact inhibition and the loss of anchorage-independence, as well as the reduced expression of tumor markers such as heat shock protein (HSP) 72 and carcinoma antigen (CA) 125. In addition, progesterone-treated cells exhibited characteristics that resembled a more differentiated phenotype. Taken together, our data indicated that progesterone was able to suppress the transformed phenotype of ovarian tumor cells. This observation could serve to explain progesterone's alleged protective effect in ovarian carcinogenesis.",
keywords = "Cell-cycle, Differentiation, Ovarian carcinoma, Progesterone",
author = "Martina Blumenthal and Adel Kardosh and Louis Dubeau and Zea Borok and Sch{\"o}nthal, {Axel H.}",
year = "2003",
month = "12",
day = "1",
doi = "10.1002/mc.10155",
language = "English (US)",
volume = "38",
pages = "160--169",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Suppression of the Transformed Phenotype and Induction of Differentiation-Like Characteristics in Cultured Ovarian Tumor Cells by Chronic Treatment with Progesterone

AU - Blumenthal, Martina

AU - Kardosh, Adel

AU - Dubeau, Louis

AU - Borok, Zea

AU - Schönthal, Axel H.

PY - 2003/12/1

Y1 - 2003/12/1

N2 - Epidemiological evidence suggests that elevated levels of the pregnancy hormone progesterone might play a role in the reduced risk of women to develop ovarian cancer. In vitro studies have supported this hypothesis by demonstrating negative effects of this hormone on the growth and proliferation of cultured ovarian carcinoma cells. However, little is known about the underlying molecular processes and how progesterone might decrease the risk for ovarian tumors. Therefore, we investigated the effects of chronic hormone treatment on the cell-cycle and transformed phenotype of ovarian carcinoma cell lines in vitro. We found that long-term treatment of these cells with progesterone caused a concomitant reduction of cyclin-dependent kinase (CDK) activity. In parallel, these cells lost their transformed phenotype as indicated by the acquisition of contact inhibition and the loss of anchorage-independence, as well as the reduced expression of tumor markers such as heat shock protein (HSP) 72 and carcinoma antigen (CA) 125. In addition, progesterone-treated cells exhibited characteristics that resembled a more differentiated phenotype. Taken together, our data indicated that progesterone was able to suppress the transformed phenotype of ovarian tumor cells. This observation could serve to explain progesterone's alleged protective effect in ovarian carcinogenesis.

AB - Epidemiological evidence suggests that elevated levels of the pregnancy hormone progesterone might play a role in the reduced risk of women to develop ovarian cancer. In vitro studies have supported this hypothesis by demonstrating negative effects of this hormone on the growth and proliferation of cultured ovarian carcinoma cells. However, little is known about the underlying molecular processes and how progesterone might decrease the risk for ovarian tumors. Therefore, we investigated the effects of chronic hormone treatment on the cell-cycle and transformed phenotype of ovarian carcinoma cell lines in vitro. We found that long-term treatment of these cells with progesterone caused a concomitant reduction of cyclin-dependent kinase (CDK) activity. In parallel, these cells lost their transformed phenotype as indicated by the acquisition of contact inhibition and the loss of anchorage-independence, as well as the reduced expression of tumor markers such as heat shock protein (HSP) 72 and carcinoma antigen (CA) 125. In addition, progesterone-treated cells exhibited characteristics that resembled a more differentiated phenotype. Taken together, our data indicated that progesterone was able to suppress the transformed phenotype of ovarian tumor cells. This observation could serve to explain progesterone's alleged protective effect in ovarian carcinogenesis.

KW - Cell-cycle

KW - Differentiation

KW - Ovarian carcinoma

KW - Progesterone

UR - http://www.scopus.com/inward/record.url?scp=0346243739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346243739&partnerID=8YFLogxK

U2 - 10.1002/mc.10155

DO - 10.1002/mc.10155

M3 - Article

C2 - 14639655

AN - SCOPUS:0346243739

VL - 38

SP - 160

EP - 169

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 4

ER -